1[1]Hughson MD, Lajoie G. Vascular disease. In: Silva FG, D'Agati VD, Nadasdy T (eds): renal biopsy interpretation. New York: Churchill Livingstone, 1996. p 333
2[2]Helmchen U, Wenzel UO. Benign and malignant nephrosclerosis and renovascular disease. In: Tisher CC, Brenner BM (eds): Renal pathology: With clinical and functional Correlations, 2nd ed. Philadelphia: JB Lippincott, 1994. p 1201
3[3]Olson JL. Hypertension: Essential and secondary forms. In: Jennette JC, Olson JL, Schwartz MM, Silva FG (eds): Heptinstall's pathology of the kidney, 5th ed. Philadelphia: Lippincott-Raven, 1998. p 943
4[4]McLaren RM, MacDonald MK. Histological and ultrastructural studies of the human juxtaglomerular apparatus in benign and malignant hypertension. J Pathol,1983,139:41
5[5]Pitcock JA, Johnson JG, Share L et al. Malignant hypertension due to musculomucoid intimal hyperplasia of intrarenal arteries. Circ Res,1975 Suppl 1,36-37:S33
6[6]Jones DB. Arterial and glomerular lesions associated with severe hypertension. Lab Invest,1974,31:303
7[7]Racusen LC, Solez K.Renal infarction, cortical necrosis, and atheroembolic disease. In: Tisher CC, Brenner BM (eds): Renal Pathology: With clinical and functional correlations, 2nd ed. Philadelphia: JB Lippincott, 1994. p 810
8[8]Kashgarian M.Acute tubular necrosis and ischemic renal injury. In: Jennette JC, Olson JL, Schwartz MM, Silva FG (eds): Heptinstall's Pathology of the Kidney, 5th ed. Philadelphia: Lippincott-Raven, 1998. p 863
9[9]Jennette JC, Falk RJ.Current concepts in renal pathology. The pathology of vasculitis involving the kidney. Am J Kidney Dis,1994,24:130
10[10]Bohle A, Helmchen U, Grund RE et al. Malignant nephrosclerosis in patients with hemolytic uremic syndrome (Primary malignant nephrosclerosis). Curr Top Pathol,1977,65:81
7Katafuchi R,Kiyoshi Y,Oh Y et al. Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation[J]. Clin Nephrol,1998,49(3):1-8.
8Harper L. Treatment of vasculitic IgA nephropathy[J]. J Nephrol, 2000,13(2):360-371.
9Quiroz Y, Pons H, Gordon KL et al. Mycophenolate mofetil prevents salt-sensitive hypetension resulting from nitric oxide synthesis inhibition[J].Am J Physiol Renal Physiol, 2001,281(1):F38-F47.
10Vanhoutte P.Endothlial dysfunction and atherosclerosis[J].Eurheart J,1997,18(Suppl):19-29.
